Navigation Links
New York State Office of Mental Health Approves New High Performance Polycarbonate Sheet for Use in All Facilities
Date:3/28/2010

Bayer Materials Science, LLC announces that its Sheffield Plastics business headquartered here has gained approval for its Makrolon® MAK 15 polycarbonate sheet as a high impact, break-resistant clear glazing material from the New York State Office of Mental Health.

Sheffield, MA (Vocus) March 28, 2010 -- Bayer Materials Science, LLC announces that its Sheffield Plastics business headquartered here has gained approval for its Makrolon® MAK 15 polycarbonate sheet as a high impact, break-resistant clear glazing material from the New York State Office of Mental Health.

The state agency approved the new product for exterior and interior applications after the material met rigorous performance standards for human impact, flammability and weathering life. These standards often serve as a benchmark for public facilities in other states as well.

According to the manufacturer, Makrolon MAK 15 is the result of a five-year R&D program with its parent-company Bayer Material Science, LLC. In addition to its inherent break-resistance, the new material delivers up to twice the abrasion resistance and weathering life due to UV exposure over prior polycarbonate sheet materials. As a result, provides longer life and reduced maintenance for external glazing and for interior partitions, windows and doors.

Based on performance improvements made possible with its new technology, Sheffield Plastics also backs Makrolon MAK 15 with an unprecedented 15 year warranty on weathering life, yellowing, abrasion resistance and breakage.

The new product is available through the manufacturer’s national network of distributors. Administrators and facilities managers can find complete information on the product at www.sheffieldplastics.com or by calling the company at 1-877- 413-7957.

Bayer MaterialScience LLC is one of the leading producers of polymers and high-performance plastics in North America and is part of the global Bayer MaterialScience business with nearly 15,100 employees at 30 sites around the world and 2008 sales of 9.7 billion euros. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction, medical, and sports and leisure industries.

Contact:
Cindy Kahlstrom
Phone: 413-528-7812
E-mail: cindy(dot)kahlstrom(at)bayerbms(dot)com

For more information about Bayer MaterialScience, call 1-800-628-5084, email us at info(at)sheffieldplastics(dot)com or visit www.sheffieldplastics.com

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our annual and interim reports filed with the Frankfurt Stock Exchange. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

# # #

Read the full story at http://www.prweb.com/releases/2010/03/prweb3790624.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Carefx Portal Solution to Deliver First Time, Statewide Access to Patient Data Among Hospitals in the LSU Network
2. MHPA Statement on Health Reform Legislation
3. Prostate Cancer Treatment Database Hits Milestone of 12,500
4. BHR Pharma Statement on Brain Injury Awareness Month - Better Awareness, Treatment, Research Needed Now
5. Statement of Ralph B. Everett, President and CEO, Joint Center for Political and Economic Studies, on House Passage of Health Reform Legislation
6. Pew Applauds Federal Grant Program Supporting State Expansion of Evidence-Based Home Visitation
7. Male Infertility Significantly Increases Risk of Prostate Cancer
8. Texas is 39th State to Defend Health Care Choice
9. Statement of US Secretary of Labor Hilda L. Solis on passage of health care reform by US House of Representatives
10. GlaxoSmithKline Statement on New Information Relating to Manufacture of Rotarix (Rotavirus Vaccine)
11. Infertility Raises Risk of More Aggressive Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New York State Office of Mental Health Approves New High Performance Polycarbonate Sheet for Use in All Facilities
(Date:12/2/2016)... ... 2016 , ... Center for Autism and Related Disorders (CARD) Portland today announced ... disorder (ASD) and other developmental disabilities. The group, which is being launched with the ... the opportunity to share stories and advice, seek help, and continue their education on ...
(Date:12/2/2016)... ... 2016 , ... U.S. Surgeon General, Dr. Vivek Murthy, graces the cover of ... was inspired to practice medicine at an early age by his father, who was ... diagnoses and prescribing medicine,” he states. “It is about building relationships with people; relationships ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... two ostomy patients, standing as living proof that attitude and determination can combine ... and issues that spike around the holidays. This campaign will offer patients a ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than half of American teens report losing ... report speaking with their child about sex related topics, less than 60 percent spoke ... proud to announce the launch of its second edition of the “Sexual Wellness” campaign, ...
(Date:12/2/2016)... ... 02, 2016 , ... CloudLIMS.com, a class-leading provider of Laboratory ... CloudLIMS Lite helps biobanks, clinical, research and testing laboratories keep track of their ... version is a faster and a more efficient product, allowing batch processing of ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... -- UCB is pleased to announce that 12 scientific abstracts have ... American Epilepsy Society (AES) Annual Meeting, which takes place ... USA. 1-12 Data being presented include ... ® (lacosamide) CV and BRIVIACT ® (brivaracetam) CV. ... state of the union of epilepsy care and antiepileptic drugs ...
(Date:12/2/2016)... -- Allergan plc (NYSE: AGN ), a leading ... announced Accelerated Share Repurchase (ASR) Program. Logo - ... , ... announced, the Company entered into a variable tenor ASR arrangement ... $10 billion of its ordinary shares. Approximately 40.5 million shares ...
(Date:11/30/2016)... , Nov 30, 2016 Research and ... Intracranial Pressure Monitoring Devices 2017 - MedCore" report to their offering. ... , , ... brain and the skull. In healthy individuals, it is circulated though the ... are cases where the amount of CSF surrounding the brain changes significantly. ...
Breaking Medicine Technology: